Health TrialsbyHealthPanel

Analgesic Efficacy of Surgeon-administered Transversus Abdominis Plane Blocks for Caesarean Section.

ConditionsCesarean Section ComplicationsPain, Postoperative
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorUniversity of Calgary

About this trial

The purpose of this research study is to evaluate whether or not adding a Transversus Abdominis Plane Block (TAP block) improves pain control for patients having a cesarean section. A TAP block is a type of nerve block where at the end of the surgery an injection of a long acting local anesthetic is made into the abdominal wall. In studies in patient's having other abdominal surgeries this has reduced the amount of narcotics patients need for pain control. This may also led to patients being more active after surgery and maybe spending less time in hospital.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

ASA status II to III

All patients undergoing elective CS under regional anesthesia at any gestational age.

Disqualifiers

- Known drug allergy to local anesthetics

Planned general anesthetic

NSAID use contraindicated post partum

Chronic pain disorder or chronic narcotic use/dependence

Trial design

Design model

Parallel

Treatments tested in this trial

  • Surgeon-administered Transversus Abdominis Plane Block 0.25% bupivicaine 0.25 mL/kg

    Other intervention

    Surgeon-administered Transversus Abdominis Plane Block

Treatment groups

80 Participants
are divided into 2 treatment groups
Group A: Surgeon-administered Transversus Abdominis Plane Block (TAP block)Experimental treatment 1 intervention
Group B: No TAP blockNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Post operative Pain

VAS scale 0-no pain to 10-worst pain

Time frame
12 hours post op

Secondary outcomes

1

Time to first request for rescue analgesia in hours

Time from completion of surgery to first request for rescue analgesia in hours

Time frame
48 hours post op
2

Post operative Opioid use

Total opioid consumption in the first 24h and 48h mark, postoperatively

Time frame
up to 48 hours post op.
3

Time from surgery to discharge from hospital

Time from completion of surgery to discharge

Time frame
Up to discharge from hospital, usually 1-3 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Calgary

Lead sponsor

Source ClinicalTrials.gov
Apply now